Cresset® Creates New Vice President Role to Lead their Artificial Intelligence (AI) Strategy
Cambridge, 15th April 2024 – Cresset an innovative provider of solutions for CADD, DMTA efficiency, and contract research, has expanded ...
News
Cambridge, UK – 29th March 2016 – Cresset, innovative provider of software and discovery services for small molecule discovery and design, is pleased to announce that Cresset’s CEO, Dr Robert Scoffin, has been awarded a Fellowship of the Royal Society of Chemistry.
Dr Robert Scoffin FRSC, is an expert in the fields of molecular modeling and cheminformatics. He joined Cresset as CEO in 2010. His previous roles include CEO of Amedis and VP, Europe at CambridgeSoft. He also heads up Re-Pharm, an early stage discovery company which uses Cresset software to assess compounds for repurposing. His DPhil is in Chemistry from the University of Oxford.
Dr Scoffin joins Cresset’s CSO, Dr Mark Mackey, as a Fellow of the RSC.